During the past decade, Horizon Oncology Center conducted 35 clinical trials. In the 10-year time frame, 35 clinical trials started and 43 clinical trials were completed, i.e. on average, 122.9% percent of trials that started reached the finish line to date. In the past 5 years, 8 clinical trials started and 21 clinical trials were completed. i.e. 262.5% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Horizon Oncology Center" #1 sponsor was "Hoosier Cancer Research Network" with 8 trials, followed by "National Cancer Institute (NCI)" with 5 trials sponsored, "Celgene" with 4 trials sponsored, "Hoffmann-La Roche" with 4 trials sponsored and "AVEO Pharmaceuticals, Inc." with 4 trials sponsored. Other sponsors include 59 different institutions and companies that sponsored additional 46 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Horizon Oncology Center" #1 collaborator was "Cancer and Leukemia Group B" with 4 trials as a collaborator, "Walther Cancer Institute" with 4 trials as a collaborator, "Genentech, Inc." with 3 trials as a collaborator, "Hoosier Cancer Research Network" with 3 trials as a collaborator and "Indiana University School of Medicine" with 3 trials as a collaborator. Other collaborators include 41 different institutions and companies that were collaborators in the rest 36 trials.

According to Clinical.Site data, the most researched conditions in "Horizon Oncology Center" are "Breast Cancer" (7 trials), "Solid Tumors" (7 trials), "Non-Small Cell Lung Cancer" (6 trials), "Multiple Myeloma" (5 trials) and "Ovarian Cancer" (4 trials). Many other conditions were trialed in "Horizon Oncology Center" in a lesser frequency.

Most popular intervention types in "Horizon Oncology Center" are "Drug" (81 trials), "Other" (10 trials), "Biological" (8 trials), "Procedure" (4 trials) and "Radiation" (3 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (7 trials), "Bevacizumab" (6 trials), "Laboratory Biomarker Analysis" (6 trials), "Cyclophosphamide" (5 trials) and "Paclitaxel" (5 trials). Other intervention names were less common.

The vast majority of trials in "Horizon Oncology Center" are 78 trials for "All" genders, 9 trials for "Female" genders and 1 trials for "Male" genders.

Currently, there are NaN active trials in "Horizon Oncology Center". undefined are not yet recruiting, 6 are recruiting, 9 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 52 completed trials in Horizon Oncology Center, undefined suspended trials, and 19 terminated clinical trials to date.

Out of the total trials that were conducted in Horizon Oncology Center, 46 "Phase 1" clinical trials were conducted, 44 "Phase 2" clinical trials and 13 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 1 trials that are defined as “Not Applicable".